A CRISPR-Cas12a-based universal rapid scrub typhus diagnostic method targeting 16S rRNA of Orientia tsutsugamushi

Bum Ju Park1,2, Sang Taek Heo3, Misun Kim3

  • 1Department of Life Science, Gachon University, Seongnam-Si, Republic of Korea.

PubMed

Insights

A new CRISPR-Cas12a diagnostic tool rapidly detects Orientia tsutsugamushi, the bacteria causing scrub typhus. This universal assay enables early diagnosis for timely antibiotic treatment and improved patient outcomes.

Area of Science:

  • Molecular Biology
  • Infectious Diseases
  • Diagnostics

Background:

  • Scrub typhus, caused by Orientia tsutsugamushi, is prevalent in the Tsutsugamushi Triangle.
  • No vaccine exists for O. tsutsugamushi; doxycycline is the primary antibiotic treatment.
  • Rapid diagnosis is crucial for effective scrub typhus treatment, reducing mortality and accelerating recovery.

Purpose of the Study:

  • To develop a novel CRISPR-Cas12a-based diagnostic method for universal detection of O. tsutsugamushi.
  • To create a diagnostic assay applicable in field settings with reduced contamination risk.

Main Methods:

  • A CRISPR-Cas12a system targeting the bacterial 16S rRNA gene was designed.
  • Both conventional two-pot and a simplified one-pot assay formats were developed.
  • The assay was validated using in vitro transcribed RNA and clinical blood samples.

Main Results:

  • The CRISPR-Cas12a method successfully detected as few as 100 copies of O. tsutsugamushi 16S rRNA within one hour under isothermal conditions.
  • The assay demonstrated high clinical sensitivity (98%) and specificity in patient blood samples.
  • The one-pot assay design enhanced field applicability and reduced contamination risks.

Conclusions:

  • The developed CRISPR-Cas12a assay provides a rapid, sensitive, and specific tool for diagnosing scrub typhus.
  • This universal diagnostic method covers all known genotypes of O. tsutsugamushi.
  • The assay facilitates timely and appropriate treatment, improving scrub typhus patient outcomes.